Dexamethasone-resistant human pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: An additional resistance mechanism

Japanese Journal of Cancer Research

Volumn 93, Issue 5, 2002, Pages 582-590

  Inoue, Hitoshi ^a   Takemura, Haruyuki ^a   Kawai, Yasukazu ^a   Yoshida, Akira ^a   Ueda, Takanori ^a   Miyashita, Toshiyuki ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

697 cells; Bcl 2; Caspase 3; Dexamethasone (DEX); Glutathione (GSH)

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BUTHIONINE SULFOXIMINE; CASP3 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 7; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLUTATHIONE; PROTEIN BCL 2; GLUCOCORTICOID; GLYCOPROTEIN P;

ARTICLE; B CELL LEUKEMIA; CELL CULTURE; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; METABOLISM; PATHOLOGY; PROGNOSIS; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; B LYMPHOCYTE; CELL DEATH; CELL LINEAGE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GLUTATHIONE METABOLISM; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS INFECTION;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASE 7; CASPASES; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; LEUKEMIA, PRE-B-CELL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, GLUCOCORTICOID; TUMOR CELLS, CULTURED;

EID: 0036316895     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01294.x     Document Type: Article

References (38)

1. Glucocorticoid resistance in childhood leukemia
2. Glucocorticoid receptors in acute leukemia
3. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: The ALL90 study of the Japan Adult Leukemia Study Group
4. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia
5. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: Preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia
6. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia
7. Prednisolone resistance in childhood acute lymphoblastic leukemia: Vitro-vivo correlations and cross-resistance to other drugs
8. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia
9. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies
10. Glucocorticoid receptors in childhood acute lymphocytic leukemia
11. Cortisol is transported by the multidrug resistance gene product P-glycoprotein
12. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
13. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias
14. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
15. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7
16. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression
17. Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukaemia
18. Glutathione in childhood acute leukaemias
19. Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells
20. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia
21. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
22. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies
23. The detection of rhodamine 123 efflux at low levels of drug resistance
24. Simultaneous treatment with 1-β-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells
25. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): No inhibition by intracellular glutathione depletion
26. Glucocorticoid receptors of normal and leukemic cells: Role of proliferation conditions
27. Attraction of proteins for small molecules and ions
28. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
29. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines
30. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
31. BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis
32. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs
33. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
34. In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro
35. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
36. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
37. Glutathione-related mechanisms in cellular resistance to anticancer drugs
38. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: Possible involvement of thiol-mediated redox regulation in pro-oxidant state